Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Inventory Average (2016 - 2018)

Historic Inventory Average for Theravance Biopharma (TBPH) over the last 5 years, with Q3 2018 value amounting to $17.9 million.

  • Theravance Biopharma's Inventory Average rose 3083.92% to $17.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $17.9 million, marking a year-over-year increase of 3083.92%. This contributed to the annual value of $14.5 million for FY2017, which is 3070.87% up from last year.
  • Latest data reveals that Theravance Biopharma reported Inventory Average of $17.9 million as of Q3 2018, which was up 3083.92% from $17.6 million recorded in Q2 2018.
  • Theravance Biopharma's 5-year Inventory Average high stood at $17.9 million for Q3 2018, and its period low was $9.6 million during Q2 2016.
  • Its 5-year average for Inventory Average is $13.2 million, with a median of $12.7 million in 2017.
  • In the last 5 years, Theravance Biopharma's Inventory Average tumbled by 2279.63% in 2016 and then surged by 3860.15% in 2018.
  • Theravance Biopharma's Inventory Average (Quarter) stood at $13.8 million in 2014, then fell by 19.98% to $11.1 million in 2015, then increased by 11.53% to $12.4 million in 2016, then increased by 29.91% to $16.0 million in 2017, then rose by 11.66% to $17.9 million in 2018.
  • Its Inventory Average was $17.9 million in Q3 2018, compared to $17.6 million in Q2 2018 and $17.0 million in Q1 2018.